Literature DB >> 22180160

DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome.

Leslie Doros1, Jiandong Yang, Louis Dehner, Christopher T Rossi, Kerry Skiver, Jason A Jarzembowski, Yoav Messinger, Kris Ann Schultz, Gretchen Williams, Nicolas André, D Ashley Hill.   

Abstract

Embryonal rhabdomyosarcoma (ERMS) is the most common childhood sarcoma and is a component of the familial pleuropulmonary blastoma (PPB)-predisposition syndrome. Using the PPB model, we hypothesized that DICER1 mutations would be found in familial and sporadic forms of ERMS. Blood samples from four children with familial PPB and ERMS, and 52 sporadic ERMS tumors were tested for DICER1 mutations. Germline DICER1 mutations were found in all four patients with familial PPB and 2 of 52 (3.8%) sporadic ERMS had somatic mutations. Our findings confirm the pathogenetic relationship between ERMS and PPB suggesting that ERMS may result from abnormal miRNA regulation.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180160      PMCID: PMC3708486          DOI: 10.1002/pbc.24020

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  17 in total

1.  Correction: Pleuropulmonary blastoma, not rhabdomyosarcoma in a congenital lung cyst.

Authors:  Shyun Pai; Hock-Liew Eng; Shin-Yi Lee; Chih-Cheng Hsaio; Wan-Ting Huang; Shun-Chen Huang; D Ashley Hill; Louis P Dehner; John R Priest
Journal:  Pediatr Blood Cancer       Date:  2007-03       Impact factor: 3.167

2.  Pediatric thyroid cancer arising as a fourth cancer in a child with pleuropulmonary blastoma.

Authors:  Angélique Rome; Jean-Claude Gentet; Carole Coze; Nicolas André
Journal:  Pediatr Blood Cancer       Date:  2008-05       Impact factor: 3.167

3.  P53 gene mutations in pleuropulmonary blastomas.

Authors:  Takeshi Kusafuka; Seika Kuroda; Masahiro Inoue; Tasnim Ara; Akihiro Yoneda; Takaharu Oue; Yuko Udatsu; Yuko Osugi; Akira Okada
Journal:  Pediatr Hematol Oncol       Date:  2002-03       Impact factor: 1.969

4.  Pleuropulmonary blastoma: a clinicopathologic study of 50 cases.

Authors:  J R Priest; M B McDermott; S Bhatia; J Watterson; J C Manivel; L P Dehner
Journal:  Cancer       Date:  1997-07-01       Impact factor: 6.860

5.  Familial association of pleuropulmonary blastoma with cystic nephroma and other renal tumors: a report from the International Pleuropulmonary Blastoma Registry.

Authors:  Françoise Boman; D Ashley Hill; Gretchen M Williams; Allen Chauvenet; Jean-Christophe Fournet; Dorothée Bouron-Dal Soglio; Yoav Messinger; John R Priest
Journal:  J Pediatr       Date:  2006-12       Impact factor: 4.406

6.  Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV.

Authors:  Lillian Sung; James R Anderson; Carola Arndt; R Beverly Raney; William H Meyer; Alberto S Pappo
Journal:  J Pediatr       Date:  2004-05       Impact factor: 4.406

Review 7.  Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry.

Authors:  Dana Ashley Hill; Jason A Jarzembowski; John R Priest; Gretchen Williams; Peter Schoettler; Louis P Dehner
Journal:  Am J Surg Pathol       Date:  2008-02       Impact factor: 6.394

8.  Pleuropulmonary blastoma: a marker for familial disease.

Authors:  J R Priest; J Watterson; L Strong; V Huff; W G Woods; R L Byrd; S H Friend; I Newsham; M D Amylon; A Pappo; D H Mahoney; C Langston; R Heyn; G Kohut; D R Freyer; B Bostrom; M S Richardson; J Barredo; L P Dehner
Journal:  J Pediatr       Date:  1996-02       Impact factor: 4.406

9.  Pleuropulmonary blastoma (pulmonary blastoma of childhood): genetic link with other embryonal malignancies?

Authors:  R Sciot; P Dal Cin; P Brock; P Moerman; B Van Damme; I De Wever; M Casteels-Van Daele; H Van den Berghe; V Desmet
Journal:  Histopathology       Date:  1994-06       Impact factor: 5.087

10.  DICER1 mutations in familial pleuropulmonary blastoma.

Authors:  D Ashley Hill; Jennifer Ivanovich; John R Priest; Christina A Gurnett; Louis P Dehner; David Desruisseau; Jason A Jarzembowski; Kathryn A Wikenheiser-Brokamp; Brian K Suarez; Alison J Whelan; Gretchen Williams; Dawn Bracamontes; Yoav Messinger; Paul J Goodfellow
Journal:  Science       Date:  2009-06-25       Impact factor: 47.728

View more
  60 in total

Review 1.  Dysregulation of microRNA biogenesis machinery in cancer.

Authors:  Akiko Hata; Risa Kashima
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-12-01       Impact factor: 8.250

2.  Germ-line and somatic DICER1 mutations in pineoblastoma.

Authors:  Leanne de Kock; Nelly Sabbaghian; Harriet Druker; Evan Weber; Nancy Hamel; Suzanne Miller; Catherine S Choong; Nicholas G Gottardo; Ursula R Kees; Surya P Rednam; Liselotte P van Hest; Marjolijn C Jongmans; Shalini Jhangiani; James R Lupski; Margaret Zacharin; Dorothée Bouron-Dal Soglio; Annie Huang; John R Priest; Arie Perry; Sabine Mueller; Steffen Albrecht; David Malkin; Richard G Grundy; William D Foulkes
Journal:  Acta Neuropathol       Date:  2014-07-15       Impact factor: 17.088

Review 3.  Imaging of the pediatric peritoneum, mesentery and omentum.

Authors:  Jonathan R Dillman; Ethan A Smith; Ajaykumar C Morani; Andrew T Trout
Journal:  Pediatr Radiol       Date:  2017-06-23

Review 4.  A network-biology perspective of microRNA function and dysfunction in cancer.

Authors:  Cameron P Bracken; Hamish S Scott; Gregory J Goodall
Journal:  Nat Rev Genet       Date:  2016-10-31       Impact factor: 53.242

Review 5.  MicroRNA biogenesis pathways in cancer.

Authors:  Shuibin Lin; Richard I Gregory
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

6.  Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome.

Authors:  Steven Klein; Hane Lee; Shahnaz Ghahremani; Pamela Kempert; Mariam Ischander; Michael A Teitell; Stanley F Nelson; Julian A Martinez-Agosto
Journal:  J Med Genet       Date:  2014-03-27       Impact factor: 6.318

7.  Expanding the spectrum of dicer1-associated sarcomas.

Authors:  Mikako Warren; Matthew C Hiemenz; Ryan Schmidt; Jared Shows; Jennifer Cotter; Stephanie Toll; David M Parham; Jaclyn A Biegel; Leo Mascarenhas; Rachana Shah
Journal:  Mod Pathol       Date:  2019-09-19       Impact factor: 7.842

8.  Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in DICER1 syndrome: a unique variant of the two-hit tumor suppression model.

Authors:  Mark Brenneman; Amanda Field; Jiandong Yang; Gretchen Williams; Leslie Doros; Christopher Rossi; Kris Ann Schultz; Avi Rosenberg; Jennifer Ivanovich; Joyce Turner; Heather Gordish-Dressman; Douglas Stewart; Weiying Yu; Anne Harris; Peter Schoettler; Paul Goodfellow; Louis Dehner; Yoav Messinger; D Ashley Hill
Journal:  F1000Res       Date:  2015-07-10

9.  Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma.

Authors:  Jason A Hanna; Catherine J Drummond; Matthew R Garcia; Jonathan C Go; David Finkelstein; Jerold E Rehg; Mark E Hatley
Journal:  Cancer Res       Date:  2017-09-15       Impact factor: 12.701

10.  Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry.

Authors:  Kris Ann P Schultz; Anne Harris; Yoav Messinger; Susan Sencer; Shari Baldinger; Louis P Dehner; D Ashley Hill
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.